Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 23;57(11):1149.
doi: 10.3390/medicina57111149.

Vojta Therapy in Neuromotor Development of Pediatrics Patients with Periventricular Leukomalacia: Case Series

Affiliations

Vojta Therapy in Neuromotor Development of Pediatrics Patients with Periventricular Leukomalacia: Case Series

Elena De-La-Barrera-Aranda et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Vojta therapy is used by physiotherapists and is based on stimulation through peripheral pressure that leads to the activation of involuntary motor response patterns, thus triggering patterns of reflex locomotion, hence also called reflex locomotion therapy. Objective: To analyze the changes produced by Vojta therapy in the evolution of infant motor development in patients with maturational delay due to periventricular leukomalacia. Materials and methods: One session of Vojta Therapy per week for eleven months, patients' neuromotor development was evaluated through the Denver II Test and the Baleys Scale. Results: A clinically significant increase in the development of the patients is observed. Conclusions: Neuromotor development seems to generate an adequate progression in the motor area.

Keywords: non-invasive therapy; pediatric neurology; physical therapy; postural control; vojta therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Second Reflex Flip Phase.
Figure 2
Figure 2
Patient score and comparison with normality based on Bayley Scale.
Figure 3
Figure 3
Patient score and comparison with normality based on DENVER Test II.

References

    1. Rogers B., Msall M., Owens T., Guernsey K., Brody A., Buck G., Hudak M. Cystic periventricular leukomalacia and type of cerebral palsy in preterm infants. J. Pediatr. 1994;125:S1–S8. doi: 10.1016/S0022-3476(94)70169-5. - DOI - PubMed
    1. Al Tawil K.I., El Mahdy H.S., Al Rifai M.T., Tamim H.M., Ahmed I.A., Al Saif S.A. Risk Factors for Isolated Periventricular Leukomalacia. Pediatr. Neurol. 2012;46:149–153. doi: 10.1016/j.pediatrneurol.2011.12.008. - DOI - PubMed
    1. Romero-Guzman G.J., Lopez-Munoz F. Prevalencia y factores de riesgo de leucomalacia periventricular en recien nacidos prematuros. Revision sistematica [Prevalence and risk factors for periventricular leukomalacia in preterm infants. A systema-tic review] Rev. Neurol. 2017;65:57–62. (In Spanish) - PubMed
    1. Armstrong D., Norman M.G. Periventricular leucomalacia in neonates: Complications and sequelae. Arch. Dis. Child. 1974;49:367–375. doi: 10.1136/adc.49.5.367. - DOI - PMC - PubMed
    1. Mulas F., Smeyers P., De Meneses M.T., Menor F. Periventricular leukomalacia: Neurological and radiological sequelae and long term neuropsychological repercussions. Rev. Neurol. 2000;31:243–252. - PubMed